ID   PAR15_HUMAN             Reviewed;         678 AA.
AC   Q460N3; J3KR47; Q8N1K3;
DT   17-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2014, sequence version 2.
DT   10-MAY-2017, entry version 111.
DE   RecName: Full=Poly [ADP-ribose] polymerase 15;
DE            Short=PARP-15;
DE            EC=2.4.2.30 {ECO:0000269|PubMed:25635049};
DE   AltName: Full=ADP-ribosyltransferase diphtheria toxin-like 7;
DE            Short=ARTD7;
DE   AltName: Full=B-aggressive lymphoma protein 3;
GN   Name=PARP15; Synonyms=BAL3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 6-678 (ISOFORM 1), AND FUNCTION.
RX   PubMed=16061477; DOI=10.1074/jbc.M505408200;
RA   Aguiar R.C.T., Takeyama K., He C., Kreinbrink K., Shipp M.A.;
RT   "B-aggressive lymphoma family proteins have unique domains that
RT   modulate transcription and exhibit poly(ADP-ribose) polymerase
RT   activity.";
RL   J. Biol. Chem. 280:33756-33765(2005).
RN   [5]
RP   NOMENCLATURE.
RX   PubMed=20106667; DOI=10.1016/j.tibs.2009.12.003;
RA   Hottiger M.O., Hassa P.O., Luscher B., Schuler H., Koch-Nolte F.;
RT   "Toward a unified nomenclature for mammalian ADP-
RT   ribosyltransferases.";
RL   Trends Biochem. Sci. 35:208-219(2010).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 481-678.
RX   PubMed=22823910; DOI=10.1021/jm300746d;
RA   Andersson C.D., Karlberg T., Ekblad T., Lindgren A.E., Thorsell A.G.,
RA   Spjut S., Uciechowska U., Niemiec M.S., Wittung-Stafshede P.,
RA   Weigelt J., Elofsson M., Schuler H., Linusson A.;
RT   "Discovery of ligands for ADP-ribosyltransferases via docking-based
RT   virtual screening.";
RL   J. Med. Chem. 55:7706-7718(2012).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 295-470 IN COMPLEX WITH
RP   SUBSTRATE.
RX   PubMed=23473667; DOI=10.1016/j.str.2012.12.019;
RA   Forst A.H., Karlberg T., Herzog N., Thorsell A.G., Gross A.,
RA   Feijs K.L., Verheugd P., Kursula P., Nijmeijer B., Kremmer E.,
RA   Kleine H., Ladurner A.G., Schuler H., Luscher B.;
RT   "Recognition of mono-ADP-ribosylated ARTD10 substrates by ARTD8
RT   macrodomains.";
RL   Structure 21:462-475(2013).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 481-678, FUNCTION, CATALYTIC
RP   ACTIVITY, AND MUTAGENESIS OF HIS-559; GLY-560 AND TYR-604.
RX   PubMed=25635049; DOI=10.1074/jbc.M114.630160;
RA   Karlberg T., Klepsch M., Thorsell A.G., Andersson C.D., Linusson A.,
RA   Schuler H.;
RT   "Structural basis for lack of ADP-ribosyltransferase activity in
RT   poly(ADP-ribose) polymerase-13/zinc finger antiviral protein.";
RL   J. Biol. Chem. 290:7336-7344(2015).
CC   -!- FUNCTION: Possesses ADP-ribosyltransferase activity
CC       (PubMed:16061477, PubMed:25635049). Transcriptional repressor
CC       (PubMed:16061477). {ECO:0000269|PubMed:16061477,
CC       ECO:0000269|PubMed:25635049}.
CC   -!- CATALYTIC ACTIVITY: NAD(+) + (ADP-D-ribosyl)(n)-acceptor =
CC       nicotinamide + (ADP-D-ribosyl)(n+1)-acceptor.
CC       {ECO:0000255|PROSITE-ProRule:PRU00397,
CC       ECO:0000269|PubMed:25635049}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q460N3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q460N3-2; Sequence=VSP_020971, VSP_020972;
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAY64451.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK097916; BAC05197.1; -; mRNA.
DR   EMBL; BC101703; AAI01704.1; -; mRNA.
DR   EMBL; BC101701; AAI01702.1; -; mRNA.
DR   EMBL; AC092908; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; DQ063586; AAY64451.1; ALT_INIT; mRNA.
DR   CCDS; CCDS3016.1; -. [Q460N3-2]
DR   CCDS; CCDS46893.1; -. [Q460N3-1]
DR   RefSeq; NP_001106995.1; NM_001113523.2. [Q460N3-1]
DR   RefSeq; NP_001295249.1; NM_001308320.1.
DR   RefSeq; NP_689828.1; NM_152615.2. [Q460N3-2]
DR   UniGene; Hs.120250; -.
DR   PDB; 3BLJ; X-ray; 2.20 A; A/B=481-678.
DR   PDB; 3GEY; X-ray; 2.20 A; A/B/C/D=481-678.
DR   PDB; 3V2B; X-ray; 2.20 A; A=295-470.
DR   PDB; 4F0E; X-ray; 2.40 A; A/B/C/D=481-678.
DR   PDBsum; 3BLJ; -.
DR   PDBsum; 3GEY; -.
DR   PDBsum; 3V2B; -.
DR   PDBsum; 4F0E; -.
DR   ProteinModelPortal; Q460N3; -.
DR   SMR; Q460N3; -.
DR   BioGrid; 127917; 1.
DR   STRING; 9606.ENSP00000417214; -.
DR   BindingDB; Q460N3; -.
DR   ChEMBL; CHEMBL2176778; -.
DR   iPTMnet; Q460N3; -.
DR   PhosphoSitePlus; Q460N3; -.
DR   BioMuta; PARP15; -.
DR   DMDM; 116248564; -.
DR   PaxDb; Q460N3; -.
DR   PeptideAtlas; Q460N3; -.
DR   PRIDE; Q460N3; -.
DR   Ensembl; ENST00000310366; ENSP00000308436; ENSG00000173200. [Q460N3-2]
DR   Ensembl; ENST00000464300; ENSP00000417214; ENSG00000173200. [Q460N3-1]
DR   GeneID; 165631; -.
DR   KEGG; hsa:165631; -.
DR   UCSC; uc003efm.3; human. [Q460N3-1]
DR   CTD; 165631; -.
DR   DisGeNET; 165631; -.
DR   GeneCards; PARP15; -.
DR   H-InvDB; HIX0200519; -.
DR   HGNC; HGNC:26876; PARP15.
DR   HPA; HPA075786; -.
DR   MIM; 612066; gene.
DR   neXtProt; NX_Q460N3; -.
DR   OpenTargets; ENSG00000173200; -.
DR   PharmGKB; PA134905094; -.
DR   eggNOG; KOG2633; Eukaryota.
DR   eggNOG; COG2110; LUCA.
DR   GeneTree; ENSGT00760000119084; -.
DR   HOGENOM; HOG000026781; -.
DR   HOVERGEN; HBG082106; -.
DR   InParanoid; Q460N3; -.
DR   KO; K15261; -.
DR   OMA; FPMIGTG; -.
DR   OrthoDB; EOG091G00EB; -.
DR   PhylomeDB; Q460N3; -.
DR   ChiTaRS; PARP15; human.
DR   EvolutionaryTrace; Q460N3; -.
DR   GenomeRNAi; 165631; -.
DR   PRO; PR:Q460N3; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000173200; -.
DR   CleanEx; HS_PARP15; -.
DR   ExpressionAtlas; Q460N3; baseline and differential.
DR   Genevisible; Q460N3; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003950; F:NAD+ ADP-ribosyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR002589; Macro_dom.
DR   InterPro; IPR034401; PARP15.
DR   InterPro; IPR012317; Poly(ADP-ribose)pol_cat_dom.
DR   PANTHER; PTHR14453:SF69; PTHR14453:SF69; 1.
DR   Pfam; PF01661; Macro; 2.
DR   Pfam; PF00644; PARP; 1.
DR   SMART; SM00506; A1pp; 2.
DR   PROSITE; PS51154; MACRO; 2.
DR   PROSITE; PS51059; PARP_CATALYTIC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Glycosyltransferase; NAD; Nucleus; Polymorphism; Reference proteome;
KW   Repeat; Transcription; Transcription regulation; Transferase.
FT   CHAIN         1    678       Poly [ADP-ribose] polymerase 15.
FT                                /FTId=PRO_0000252436.
FT   DOMAIN       78    267       Macro 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00490}.
FT   DOMAIN      293    464       Macro 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00490}.
FT   DOMAIN      482    678       PARP catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00397}.
FT   REGION      312    313       Substrate binding. {ECO:0000244|PDB:3V2B,
FT                                ECO:0000269|PubMed:23473667}.
FT   REGION      324    325       Substrate binding. {ECO:0000244|PDB:3V2B,
FT                                ECO:0000269|PubMed:23473667}.
FT   REGION      409    413       Substrate binding. {ECO:0000244|PDB:3V2B,
FT                                ECO:0000269|PubMed:23473667}.
FT   BINDING     331    331       Substrate. {ECO:0000244|PDB:3V2B,
FT                                ECO:0000269|PubMed:23473667}.
FT   BINDING     335    335       Substrate; via amide nitrogen.
FT                                {ECO:0000244|PDB:3V2B,
FT                                ECO:0000269|PubMed:23473667}.
FT   BINDING     449    449       Substrate. {ECO:0000244|PDB:3V2B,
FT                                ECO:0000269|PubMed:23473667}.
FT   VAR_SEQ       1    234       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_020971.
FT   VAR_SEQ     235    256       RPITSPLQEVHFLVYTNDDEGC -> MLQRIGLIFLHNIVV
FT                                VSNCFYF (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_020972.
FT   VARIANT     337    337       R -> K (in dbSNP:rs6793271).
FT                                /FTId=VAR_027862.
FT   VARIANT     521    521       A -> T (in dbSNP:rs34383355).
FT                                /FTId=VAR_056658.
FT   VARIANT     628    628       G -> R (in dbSNP:rs12489170).
FT                                /FTId=VAR_027863.
FT   MUTAGEN     559    559       H->Y: Abolishes catalytic activity.
FT                                {ECO:0000269|PubMed:25635049}.
FT   MUTAGEN     560    560       G->A: Slightly reduces catalytic
FT                                activity. Abolishes activity; when
FT                                associated with Y-559 and C-604.
FT                                {ECO:0000269|PubMed:25635049}.
FT   MUTAGEN     604    604       Y->C: Reduces catalytic activity 20-fold.
FT                                Abolishes activity; when associated with
FT                                Y-559 and A-560.
FT                                {ECO:0000269|PubMed:25635049}.
FT   CONFLICT     42     42       V -> M (in Ref. 4; AAY64451).
FT                                {ECO:0000305}.
FT   STRAND      296    301       {ECO:0000244|PDB:3V2B}.
FT   STRAND      304    311       {ECO:0000244|PDB:3V2B}.
FT   HELIX       313    315       {ECO:0000244|PDB:3V2B}.
FT   STRAND      318    325       {ECO:0000244|PDB:3V2B}.
FT   HELIX       335    343       {ECO:0000244|PDB:3V2B}.
FT   HELIX       345    355       {ECO:0000244|PDB:3V2B}.
FT   STRAND      361    366       {ECO:0000244|PDB:3V2B}.
FT   STRAND      370    379       {ECO:0000244|PDB:3V2B}.
FT   HELIX       384    397       {ECO:0000244|PDB:3V2B}.
FT   STRAND      402    405       {ECO:0000244|PDB:3V2B}.
FT   HELIX       417    434       {ECO:0000244|PDB:3V2B}.
FT   STRAND      442    449       {ECO:0000244|PDB:3V2B}.
FT   HELIX       451    461       {ECO:0000244|PDB:3V2B}.
FT   STRAND      493    498       {ECO:0000244|PDB:3BLJ}.
FT   HELIX       504    517       {ECO:0000244|PDB:3BLJ}.
FT   STRAND      520    530       {ECO:0000244|PDB:3BLJ}.
FT   HELIX       531    547       {ECO:0000244|PDB:3BLJ}.
FT   STRAND      548    550       {ECO:0000244|PDB:3BLJ}.
FT   STRAND      554    561       {ECO:0000244|PDB:3BLJ}.
FT   HELIX       563    565       {ECO:0000244|PDB:3BLJ}.
FT   HELIX       566    572       {ECO:0000244|PDB:3BLJ}.
FT   TURN        576    578       {ECO:0000244|PDB:3BLJ}.
FT   STRAND      588    595       {ECO:0000244|PDB:3BLJ}.
FT   HELIX       596    600       {ECO:0000244|PDB:3BLJ}.
FT   TURN        602    604       {ECO:0000244|PDB:3BLJ}.
FT   STRAND      613    621       {ECO:0000244|PDB:3BLJ}.
FT   STRAND      624    627       {ECO:0000244|PDB:3BLJ}.
FT   STRAND      637    639       {ECO:0000244|PDB:3BLJ}.
FT   STRAND      642    646       {ECO:0000244|PDB:3GEY}.
FT   STRAND      648    652       {ECO:0000244|PDB:3BLJ}.
FT   STRAND      654    656       {ECO:0000244|PDB:3BLJ}.
FT   STRAND      658    662       {ECO:0000244|PDB:3BLJ}.
FT   STRAND      667    677       {ECO:0000244|PDB:3BLJ}.
SQ   SEQUENCE   678 AA;  74576 MW;  E299386DA4B2BF8C CRC64;
     MAAPGPLPAA ALSPGAPTPR ELMHGVAGVT SRAGRDREAG SVLPAGNRGA RKASRRSSSR
     SMSRDNKFSK KDCLSIRNVV ASIQTKEGLN LKLISGDVLY IWADVIVNSV PMNLQLGGGP
     LSRAFLQKAG PMLQKELDDR RRETEEKVGN IFMTSGCNLD CKAVLHAVAP YWNNGAETSW
     QIMANIIKKC LTTVEVLSFS SITFPMIGTG SLQFPKAVFA KLILSEVFEY SSSTRPITSP
     LQEVHFLVYT NDDEGCQAFL DEFTNWSRIN PNKARIPMAG DTQGVVGTVS KPCFTAYEMK
     IGAITFQVAT GDIATEQVDV IVNSTARTFN RKSGVSRAIL EGAGQAVESE CAVLAAQPHR
     DFIITPGGCL KCKIIIHVPG GKDVRKTVTS VLEECEQRKY TSVSLPAIGT GNAGKNPITV
     ADNIIDAIVD FSSQHSTPSL KTVKVVIFQP ELLNIFYDSM KKRDLSASLN FQSTFSMTTC
     NLPEHWTDMN HQLFCMVQLE PGQSEYNTIK DKFTRTCSSY AIEKIERIQN AFLWQSYQVK
     KRQMDIKNDH KNNERLLFHG TDADSVPYVN QHGFNRSCAG KNAVSYGKGT YFAVDASYSA
     KDTYSKPDSN GRKHMYVVRV LTGVFTKGRA GLVTPPPKNP HNPTDLFDSV TNNTRSPKLF
     VVFFDNQAYP EYLITFTA
//
